ArticleCancers2023

A Retrospective Study Comparing Olaparib and Bevacizumab as a Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: Impact on Recurrence-Free Survival in Japanese and Asian Populations.

Kazuho Nakanishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.